4u6l
From Proteopedia
(Difference between revisions)
| Line 3: | Line 3: | ||
<StructureSection load='4u6l' size='340' side='right'caption='[[4u6l]], [[Resolution|resolution]] 1.90Å' scene=''> | <StructureSection load='4u6l' size='340' side='right'caption='[[4u6l]], [[Resolution|resolution]] 1.90Å' scene=''> | ||
== Structural highlights == | == Structural highlights == | ||
| - | <table><tr><td colspan='2'>[[4u6l]] is a 2 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4U6L OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=4U6L FirstGlance]. <br> | + | <table><tr><td colspan='2'>[[4u6l]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/Synthetic_construct Synthetic construct]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4U6L OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=4U6L FirstGlance]. <br> |
| - | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat | + | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=5CM:5-METHYL-2-DEOXY-CYTIDINE-5-MONOPHOSPHATE'>5CM</scene>, <scene name='pdbligand=NCO:COBALT+HEXAMMINE(III)'>NCO</scene>, <scene name='pdbligand=SR:STRONTIUM+ION'>SR</scene></td></tr> |
| - | + | ||
| - | + | ||
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4u6l FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4u6l OCA], [https://pdbe.org/4u6l PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4u6l RCSB], [https://www.ebi.ac.uk/pdbsum/4u6l PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4u6l ProSAT]</span></td></tr> | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4u6l FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4u6l OCA], [https://pdbe.org/4u6l PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4u6l RCSB], [https://www.ebi.ac.uk/pdbsum/4u6l PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4u6l ProSAT]</span></td></tr> | ||
</table> | </table> | ||
| - | <div style="background-color:#fffaf0;"> | ||
| - | == Publication Abstract from PubMed == | ||
| - | It has been confirmed by our previous studies that a 2',4'-BNA(NC)[N-Me]-modified antisense gapmer displays high affinity and selectivity to the target RNA strand, promising mRNA inhibitory activity and excellent nuclease resistance. Herein, we have obtained a crystal structure that provides insights into these excellent antisense properties. | ||
| - | |||
| - | The crystal structure of a 2',4'-BNA(NC)[N-Me]-modified antisense gapmer in complex with the target RNA.,Kondo J, Nomura Y, Kitahara Y, Obika S, Torigoe H Chem Commun (Camb). 2016 Feb 7;52(11):2354-7. doi: 10.1039/c5cc08300a. PMID:26731288<ref>PMID:26731288</ref> | ||
| - | |||
| - | From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | ||
| - | </div> | ||
| - | <div class="pdbe-citations 4u6l" style="background-color:#fffaf0;"></div> | ||
| - | == References == | ||
| - | <references/> | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
[[Category: Large Structures]] | [[Category: Large Structures]] | ||
| - | [[Category: Kitahara | + | [[Category: Synthetic construct]] |
| - | [[Category: Kondo | + | [[Category: Kitahara Y]] |
| - | [[Category: Nomura | + | [[Category: Kondo J]] |
| - | [[Category: Obika | + | [[Category: Nomura Y]] |
| - | [[Category: Torigoe | + | [[Category: Obika S]] |
| - | + | [[Category: Torigoe H]] | |
| - | + | ||
| - | + | ||
Current revision
Crystal structure of DNA/RNA duplex obtained in the presence of [Co(NH3)6]Cl3 and SrCl2
| |||||||||||
